All Stories

  1. Efficacy and safety of adalimumab after failure of other anti-TNFα agents for plaque-type psoriasis: clinician behavior in real life clinical practice

    Article • Journal of Dermatological Treatment, November 2018, Taylor & Francis

    Professor Luca Stingeni, Franco Rongioletti